🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark S. Cohen

Rush University Medical Center

ORCID: 0000-0002-2517-0757

Also affiliated with Carle Foundation Hospital, University of Illinois Urbana-Champaign, Illinois College, University of Illinois System

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “RETRACTED: Novel C‐terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self‐renewal, and epithelial–mesenchymal transition”.

RETRACTED: Novel C‐terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self‐renewal, and epithelial–mesenchymal transition

Molecular Oncology(2020)10.1002/1878-0261.12686

N/A

0DataRank · unranked

19 citations

Patrick T. Grogan, Ton Wang, Joseph Bazzill, Ang Zuo, Peter White +6 more

A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro

Surgery(2020)10.1016/j.surg.2020.06.009

N/A

0DataRank · unranked

13 citations

Rebecca M. Gorney, Ton Wang, Derek Ge, Nina Zhang, Ang Zuo +3 more

Advances in the discovery and development of melanoma drug therapies

Expert Opinion on Drug Discovery(2021)10.1080/17460441.2021.1942834

N/A

0DataRank · unranked

17 citations

Mark S. Cohen, Monica Chanda

Re-Evaluation of Combinational Efficacy and Synergy of the Italian Protocol In Vitro: Are We Truly Optimizing Benefit or Permitting Unwanted Toxicity?

Biomedicines(2021)10.3390/biomedicines9091190

N/A

0DataRank · unranked

1 citations

Reid McCallister, Dawn Kuszynski, Mark S. Cohen, Chitra Subramanian

CryoEM Structure with ATP Synthase Enables Late‐Stage Diversification of Cruentaren A

Chemistry - A European Journal(2023)10.1002/chem.202300262

N/A

0DataRank · unranked

0 citations

Hui Guo, Terin D’Amico, Leah Abdallah, Chitra Subramanian, Bhargav A. Patel +4 more

Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway

Surgery(2024)10.1016/j.surg.2024.07.075

N/A

0DataRank · unranked

9 citations

Kelli McNamara, Seth W. Croslow, Yanqi Tan, Daniel L. Hess, Katja Kiseljak‐Vassiliades +4 more

The Investigation of Hsp90C‐Terminal Inhibitors Containing Amide Bioisosteres

ChemMedChem(2024)10.1002/cmdc.202400418

N/A

0DataRank · unranked

2 citations

Chitra Subramanian, Reagan Long, Kelli McNamara, Mark S. Cohen, Brian S. J. Blagg +1 more

Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities

RSC Medicinal Chemistry(2024)10.1039/d3md00529a

N/A

0DataRank · unranked

7 citations

Chitra Subramanian, Mark S. Cohen, Brian S. J. Blagg, Eva Amatya

A novel therapeutic approach to adrenocortical carcinoma repurposing fingolimod to target sphingolipid metabolism in metastatic disease

Surgery(2025)10.1016/j.surg.2025.109702

N/A

0DataRank · unranked

0 citations

Kelli McNamara, Daniel L. Hess, Seth Croslow, Yanqi Tan, Katja Kiseljak‐Vassiliades +4 more